Literature DB >> 16879288

EFNS guideline on diagnosis and management of post-polio syndrome. Report of an EFNS task force.

E Farbu1, N E Gilhus, M P Barnes, K Borg, M de Visser, A Driessen, R Howard, F Nollet, J Opara, E Stalberg.   

Abstract

Post-polio syndrome (PPS) is characterized by new or increased muscular weakness, atrophy, muscle pain and fatigue several years after acute polio. The aim of the article is to prepare diagnostic criteria for PPS, and to evaluate the existing evidence for therapeutic interventions. The Medline, EMBASE and ISI databases were searched. Consensus in the group was reached after discussion by e-mail. We recommend Halstead's definition of PPS from 1991 as diagnostic criteria. Supervised, aerobic muscular training, both isokinetic and isometric, is a safe and effective way to prevent further decline for patients with moderate weakness (Level B). Muscular training can also improve muscular fatigue, muscle weakness and pain. Training in a warm climate and non-swimming water exercises are particularly useful (Level B). Respiratory muscle training can improve pulmonary function. Recognition of respiratory impairment and early introduction of non-invasive ventilatory aids prevent or delay further respiratory decline and the need for invasive respiratory aid (Level C). Group training, regular follow-up and patient education are useful for the patients' mental status and well-being. Weight loss, adjustment and introduction of properly fitted assistive devices should be considered (good practice points). A small number of controlled studies of potential-specific treatments for PPS have been completed, but no definitive therapeutic effect has been reported for the agents evaluated (pyridostigmine, corticosteroids, amantadine). Future randomized trials should particularly address the treatment of pain, which is commonly reported by PPS patients. There is also a need for studies evaluating the long-term effects of muscular training.

Entities:  

Mesh:

Substances:

Year:  2006        PMID: 16879288     DOI: 10.1111/j.1468-1331.2006.01385.x

Source DB:  PubMed          Journal:  Eur J Neurol        ISSN: 1351-5101            Impact factor:   6.089


  26 in total

1.  Comorbidity profile of poliomyelitis survivors in a Chinese population: a population-based study.

Authors:  Jiunn-Horng Kang; Herng-Ching Lin
Journal:  J Neurol       Date:  2011-01-30       Impact factor: 4.849

2.  IVIG treatment in post-polio patients: evaluation of responders.

Authors:  Gunilla Ostlund; Lisbet Broman; Lars Werhagen; Kristian Borg
Journal:  J Neurol       Date:  2012-05-17       Impact factor: 4.849

3.  Total hip arthroplasty performed in patients with residual poliomyelitis: does it work?

Authors:  Byung-Ho Yoon; Young-Kyun Lee; Jeong Joon Yoo; Hee Joong Kim; Kyung-Hoi Koo
Journal:  Clin Orthop Relat Res       Date:  2013-11-08       Impact factor: 4.176

4.  Pyridostigmine: Postpoliomyelitis Syndrome.

Authors:  Joyce A Generali; Dennis J Cada
Journal:  Hosp Pharm       Date:  2016-05

5.  Risk factors for post-polio syndrome among an Italian population: a case-control study.

Authors:  Laura Bertolasi; Michele Acler; Elisa dall'Ora; Alberto Gajofatto; Emma Frasson; Pierluigi Tocco; Mara Turri; Monica Ferlisi; Michele Fiorini; Fabiana Pimazzoni; Giovanna Squintani; Millo Martini; Bruno Danzi; Salvatore Monaco
Journal:  Neurol Sci       Date:  2012-01-14       Impact factor: 3.307

6.  Analysis of long-standing nociceptive and neuropathic pain in patients with post-polio syndrome.

Authors:  Lars Werhagen; Kristian Borg
Journal:  J Neurol       Date:  2010-03-30       Impact factor: 4.849

7.  Update on current and emerging treatment options for post-polio syndrome.

Authors:  Elisabeth Farbu
Journal:  Ther Clin Risk Manag       Date:  2010-07-21       Impact factor: 2.423

8.  Hypothyroid myopathy mimicking postpolio syndrome.

Authors:  Rajesh Verma; Rakesh Lalla; Ritesh Sahu
Journal:  BMJ Case Rep       Date:  2012-08-24

9.  Survey of young patients with polio and a foreign background at a Swedish post-polio outpatient clinic.

Authors:  Lars Werhagen; Kristian Borg
Journal:  Neurol Sci       Date:  2016-06-14       Impact factor: 3.307

10.  Exercise therapy and cognitive behavioural therapy to improve fatigue, daily activity performance and quality of life in postpoliomyelitis syndrome: the protocol of the FACTS-2-PPS trial.

Authors:  Fieke S Koopman; Anita Beelen; Karin H Gerrits; Gijs Bleijenberg; Tineke A Abma; Marianne de Visser; Frans Nollet
Journal:  BMC Neurol       Date:  2010-01-18       Impact factor: 2.474

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.